Clinical Trial Update: Efficacy and Safety Study of Thioctacid Oral Tablets 600mg to Treat Chinese Diabetic Patients With Distal Symmetric Polyneuropathy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for Thioctacid (alpha-lipoic acid) 600 mg oral tablets investigating efficacy and safety in Chinese diabetic patients with distal symmet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Polyneuropathy
• Distal Symmetric Polyneuropathy

Drugs mentioned

• Thioctacid (alpha-lipoic acid)

Snippet

Sponsor: NovaMed Pharmaceuticals Inc. | Conditions: Diabetics | Phase 2, Phase 3 | Status: UNKNOWN